Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Positive phase I results for Cytovaxine

Oct. 6, 2003

Roche and Protein Design Labs restructure Zenapax alliance

Oct. 3, 2003

Ariad scientists design new rapamycin-based immunosuppressants

Oct. 1, 2003

FluINsure shows positive results in influenza challenge study

Sep. 25, 2003

New IgE production inhibitors in early development at Novartis

Sep. 18, 2003

Grants support work on ricin vaccine technology

Sep. 18, 2003

Schering researchers present new inhibitors of IL-12 and IFNgamma production

Sep. 16, 2003

BMS designs series of potent and selective Itk inhibitors as potential immunosuppressants

Sep. 15, 2003

Everolimus alleviates cardiac vasculopathy after heart transplant

Sep. 10, 2003

Fujisawa claims novel adenosine deaminase inhibitors and their use

Sep. 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...